Twitter sorry for letting adverts target neo-Nazis
Social network apologises for allowing the use of discriminatory ad keywords it had meant to ban.
Related Articles
2024 Transplant and Cellular Therapy Options for Non-Malignant Disorders – MSK Continuing Medical Education – Continuing Education (CE)
MSK Continuing Medical Education, 2024 Transplant and Cellular Therapy Options for Non-Malignant Disorders, 10/24/2024 8:30:00 AM – 10/25/2024 4:15:00 PM, Advancements in therapies for non-malignant…
The Movement to Beat Rare Cancers | Cycle for Survival
Together, let’s bring new and better treatment options to people with cancer. 100% of all money raised directly funds lifesaving rare cancer research at Memorial…
Tesla blamed drivers for failures of parts it long knew were defective
Tesla records reveal the automaker has long known far more about the extent of defects than it has disclosed to consumers and safety regulators.
Tesla blamed drivers for failures of parts it long knew were defective
Tesla records reveal the automaker has long known far more about the extent of defects than it has disclosed to consumers and safety regulators.
Tesla blamed drivers for failures of parts it long knew were defective
Tesla records reveal the automaker has long known far more about the extent of defects than it has disclosed to consumers and safety regulators.
ASTCT Response to FDA Approval of Gene Therapies for Treatment of Sickle Cell Disease (SCD)
The American Society for Transplantation and Cellular Therapy® (ASTCT®) recognizes the US Food and Drug Administration’s (FDA) recently granted a …
ASTCT Response to FDA Approval of Gene Therapies for Treatment of Sickle Cell Disease (SCD)
The American Society for Transplantation and Cellular Therapy® (ASTCT®) recognizes the US Food and Drug Administration’s (FDA) recently granted a …
Miguel Perales M.D. (@drmiguelperales) on Threads
Chief, Adult BMT Service @memorialsloankettering President @ASTCT Past Board Member @BeTheMatch – opinions mine/not my employer’s. 151 Followers.
8 Reasons Why MSK Is a Leader in Stem Cell and Bone Marrow Transplants
The year 2023 marks the 50th anniversary of the first-ever transplant of bone marrow from a donor to a patient who was not related, which…
Dr. Perales: «Faltan donantes de células madre en España»
La enfermedad de injerto contra receptor crónica afecta al 10-30% de pacientes infantiles y al 30-70% de los adultos, explica el Dr. Miguel-Ángel Perales, jefe…